FINRA's Double BindPrivate for the Constitution, Public for Immunity

The core contradiction

FINRA (Financial Industry Regulatory Authority) occupies a legal position that critics describe as "heads I win, tails you lose": in constitutional litigation, courts treat it as a private corporation with no obligation to comply with the Constitution — yet in civil liability suits, the same courts have treated it as if it were a government body, granting it absolute immunity from damages claims arising out of its regulatory conduct. Securities lawyer Russ Ryan and the New Civil Liberties Alliance (NCLA) have made this exact point: FINRA and similar self-regulatory organizations (SROs) are simultaneously shielded from constitutional constraints because they're "private," and shielded from lawsuits because they're treated as quasi-governmental.

Where the immunity comes from

Unlike FINRA's SEC-approved rulebook, this immunity was never enacted by Congress. It's judge-made doctrine, built case by case starting in the 1980s. The key modern statement comes from the Second Circuit in Standard Investment Chartered, Inc. v. NASD (2011): SROs and their officers get absolute immunity from private damages suits connected to the discharge of their regulatory responsibilities, because that immunity "protects private actors when they perform important governmental functions." Other circuits, including the Ninth, have echoed the same reasoning — describing SROs as "quasi-governmental authorities" because the SEC has delegated regulatory power to them.

That immunity is broad, not narrow. Courts have applied it to:

• Disciplinary proceedings against member firms
• Rule enforcement and general oversight
• Interpretation of securities laws and regulations
• Referrals to the SEC or other agencies for civil or criminal enforcement
• Public announcements of regulatory decisions
• Both affirmative acts and omissions or failures to act

Litigants have tried to carve out an exception for fraud allegations specifically. Courts have refused every time — immunity applies regardless of whether the plaintiff is a public investor or an SRO member.

An illustrative case: Standard Investment Chartered v. NASD

When NASD and NYSE merged their regulatory arms to form FINRA, NASD amended its bylaws to change member voting rights as part of that consolidation. A shareholder sued, alleging the proxy solicitation for that bylaw change was fraudulent. The Second Circuit held the suit couldn't proceed: the bylaw amendment was "incident to" NASD's regulatory function, since it was a necessary step toward consolidating the two organizations' regulatory duties into FINRA — and that made it immune, even though a shareholder vote and corporate bylaws sound like ordinary private-corporate matters, not government regulation. The Cato Institute, joined by the Competitive Enterprise Institute, filed a brief urging the Supreme Court to take the case, arguing this shows how far "incident to" immunity can stretch, and how little transparency or accountability SROs face as a result — with the SEC largely failing to fill the gap and the judiciary left as the only real check.

Why this might be cracking now: Galette v. New Jersey Transit

NCLA's Russ Ryan argues a 2026 Supreme Court decision may undermine this whole line of cases — even though it has nothing to do with securities law. Galette v. New Jersey Transit Corporation was a sovereign-immunity case involving a state transit agency. But the unanimous reasoning the Court used to narrow immunity there is, in Ryan's view, hard to square with giving FINRA (or the PCAOB, another SRO-like body) absolute immunity — because unlike a state transit agency, FINRA is a legally independent private corporation: it wasn't created by the government, and none of its leadership is government-appointed. Ryan's argument: the Supreme Court has never explicitly blessed absolute immunity for SROs in the first place, and Galette's narrower approach opens the door to challenging it directly.

How this connects to the "is FINRA constitutional" fight

The immunity question and the constitutionality question are two sides of the same coin, and litigants have started pressing both together. In the ongoing Alpine Securities Corp. v. FINRA litigation:

• A D.C. Circuit panel found a likely violation of the "private nondelegation" doctrine and blocked FINRA from summarily expelling a member firm without contemporaneous SEC review.
• One judge on that panel went further, arguing in a partial dissent that FINRA's combined investigative, prosecutorial, and adjudicatory roles amount to executive power that constitutionally must be exercised by officers accountable under Article II of the Constitution.
• At the district court level, however, a federal judge ruled against Alpine on seven of eight counts, holding FINRA is a private entity operating under sufficient SEC oversight, and rejecting the appointments-clause and nondelegation arguments.
• In August 2026, the Supreme Court declined to hear Alpine's case, ending that specific path to the Court — though Alpine's broader case continues in the D.C. District, and a related case (Boustead) is pressing similar claims about the structure of FINRA's enforcement forum.

The human cost

“I am currently involved in a live FINRA enforcement matter in which a FINRA enforcement officer I knew from college—against whom I had exercised ordinary social boundaries years earlier—initiated a proceeding against me without evidence of wrongdoing, which I believe was done in retaliation. I have spent approximately $500,000 in legal fees to defend myself, and I do not expect any internal FINRA appeal to succeed until the matter can be reviewed by the SEC. This experience has convinced me that FINRA enforcement must be restructured so that it operates within, and is accountable to, the SEC rather than functioning as an immune entity outside the federal government. Instead, a single FINRA enforcement officer was permitted to act with effectively unchecked discretion, subjecting me to years of burdensome document requests and procedural demands that served no legitimate regulatory purpose.”

The one-sentence version

FINRA's opponents argue that no organization should get to pick the more favorable label depending on which lawsuit it's facing: "private" when the Constitution is the plaintiff's weapon, "governmental" when tort or fraud liability is. Whether that argument prevails now may hinge less on the securities cases themselves than on how far courts let an unrelated transit-agency ruling ("Galette") reach into SRO doctrine.

Sources

• New Civil Liberties Alliance, A Welcome SCOTUS Blow Against Pseudo-Governmental Immunity (May 2026)
• SecLaw.com, FINRA's Immunity, summarizing Russ Ryan's analysis of Galette v. New Jersey Transit
• Cato Institute, Financial Regulators Are Not Above the Constitution and Cato's amicus brief in Standard Investment Chartered, Inc. v. NASD
• Robert D. Mitchell, FINRA Immunity from Civil Claims, citing Standard Investment Chartered, Inc. v. NASD, 637 F.3d 112 (2d Cir. 2011); Sparta Surgical Corp. v. NASD, 159 F.3d 1209 (9th Cir. 1998); DL Capital Group, LLC v. NASDAQ Stock Market, Inc., 409 F.3d 93 (2d Cir. 2005)
• SecuritiesArbitrations.com, coverage of the Second Circuit's Standard decision
• Carlton Fields (Opalesque), Other Voices: FINRA's Sky Isn't Falling (Just Yet)
• Bloomberg Law and Bloomberg Tax, coverage of Alpine Securities Corp. v. FINRA
• Shumaker client alert, FINRA Under Fire: New Lawsuit Challenges the Constitutionality of Its Enforcement Power
• AltsWire, Court Dismisses Alpine's Constitutional Challenge to FINRA Authority
• Coverage of the Supreme Court's certiorari denial in Alpine Securities v. FINRA (August 2026)

Note: This article summarizes ongoing, unsettled litigation and reflects the state of these cases as of September 2026. Several proceedings are still active and outcomes may change. It is published for educational purposes and is not legal advice.